SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a memecoin on the Bitcoin network, is trending as the community rallies around its potential as the first fair-launched meme on Bitcoin L2 with big names and whales watching. Discussions revolve around its strong community, decentralized nature, and the possibility of reaching $1, with some highlighting its role in driving demand for Bitcoin blockspace. The 'DOG Army' is actively promoting the token, emphasizing its unique position within the Bitcoin ecosystem.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation of a potential licensing deal with AstraZeneca and positive sentiment surrounding its cancer drug, ivonescimab. The community is actively discussing the possibility of a significant upfront payment and the potential for the drug to challenge existing treatments. Anticipation is building as investors await further news and data releases, with some highlighting the stock's high short interest as a catalyst for a potential squeeze.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as a potential Real World Asset (RWA) coin, drawing comparisons to $XRP.X and $XLM.X. The community highlights its low market cap and potential for integration with the XRP ledger, viewing it as an early opportunity. Community members are actively discussing where to buy the coin and sharing enthusiasm for its potential gains.

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Resmed Inc.

ResMed ($RMD) is trending amid speculation about a potential buyout or partnership with Incannex ($IXHL), driven by positive clinical trial data for a sleep apnea pill that could disrupt the CPAP market. The community is closely watching for an announcement, especially given that a ResMed executive is on Incannex's advisory board, with some speculating this is a strategic move before Phase 3 trials.

Numeraire

Numeraire is trending as traders discuss a recent investment from a major US bank into the AI-based crypto hedge fund, which some believe could lead to significant growth. The community is actively analyzing price charts, identifying potential breakout points, and anticipating further upward momentum. With a relatively low circulating supply, many are speculating on substantial long-term gains.

Sapien is an open protocol for sourcing verified human knowledge at scale. Its network of millions of contributors spans more than 100 countries, ranging from doctors and engineers to artists and students. Together they produce high-quality AI training data, validated through Sapien’s onchain Proof of Quality system. This ensures enterprises and AI developers can access trusted, human-in-the-loop data while transforming fragmented online work into a sustainable, reputation-based profession. Incentives across the network are powered by the $SAPIEN token, an ERC-20 asset on Base.

Sapien

Sapien.X is trending as the community discusses its potential for significant gains, with some drawing comparisons to other recently successful tokens. The token's chart setup and appealing levels are generating interest, while others speculate about potential scams. The recent listing and overall market conditions abroad are also being mentioned as potential catalysts.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending as traders discuss its low float and potential for a significant price surge, reminiscent of other recent low float runners. Community members are highlighting the stock's scarce shares and growing watcher count, suggesting a possible squeeze. Some are pointing to a recent land sale that could boost NAV.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

BBBY is trending as the ticker reactivates, sparking confusion and discussion among traders about Overstock's acquisition of the Bed Bath & Beyond brand and its implications for previous shareholders. The community is actively debating the company's future, potential partnerships, and the possibility of a short squeeze, drawing comparisons to the $GME saga. Some investors express skepticism, citing past financial difficulties, while others see potential in the company's blockchain initiatives.

ONDO is a DeFi primitive that enables users to originate risk-isolated, fixed yield loans backed by yield-generating crypto-assets. It's unique because it's a permissionless protocol that allows users to interact on a peer-to-pool basis with no intermediaries.

Ondo

ONDO.X is trending as investors discuss its potential in the Real World Asset (RWA) tokenization space and its collaborations with major financial institutions. Community members are weighing the impact of token unlocks and governance, while anticipating broader market attention and future catalysts like ETFs. Some traders express frustration with short-term price action, while remaining bullish on ONDO's long-term prospects.

Meet Mochi, the cutest IP on Base – Named after Coinbase CEO Brian Armstrong’s pet cat! Launched before Base’s main-net launch in August 2023, Mochi is a first mover on Base, and is committed to help Base and Coinbase is their mission to bring the next billion users onchain.   Mochi has already received a grant from Coinbase for its efforts to onboard new users and continues to release news and developments that see recognition from Coinbase and Base team members and the wider Base community.   Designed by the artist behind Pudgy Penguins, Antoine Mingo - Mochi’s IP has accrued billions of GIF views globally and gained a large non-crypto native following on social media platforms such as Instagram. Mochi’s mission is to become the most retail friendly IP on Base and position itself for the millions of retail investors being onboarded to Base in 2025 through Coinbase and Base’s efforts.   Join Mochi and the vibrant Mochi community in achieving this mission through weekly initiatives and many exciting developments yet to come and be a part of Base’s journey to becoming the largest onchain economy in crypto!

Mochi

Mochi.X is trending as users discuss its potential Coinbase listing and its relationship to $TOSHI.X, with some suggesting that Mochi could see significant gains if listed on major exchanges. Community members highlight the potential for high returns due to its lower market cap compared to other meme coins on the Base chain, and some are accumulating, viewing it as a long-term hold.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is UFP Industries (UFPI) Up 2.6% Since Last Earnings Report?

UFP Industries (UFPI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's What to Know Ahead of Martin Marietta's Q2 Earnings Release

MLM is expected to post higher Q2 earnings on strong aggregates pricing and public infrastructure demand.

Vulcan's Q2 Earnings & Revenues Miss Estimates, Both Up Y/Y

VMC posts Q2 revenue and earnings growth despite volume declines, but misses estimates; stock dips as shipment weakness weighs.

Comfort Systems Stock Up 14% on Q2 Earnings & Revenue Beat

FIX surges 14% after Q2 earnings crush estimates, with record profit, rising backlog, and expanding margins fueling growth.

Weyerhaeuser's Q2 Earnings & Sales Top Estimates, Both Down Y/Y

WY beats Q2 estimates, but EPS and sales fell year over year as wood product pricing and cost pressures dragged margins.

Weyerhaeuser (WY) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Weyerhaeuser (WY) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Weyerhaeuser (WY) Beats Q2 Earnings and Revenue Estimates

Weyerhaeuser (WY) delivered earnings and revenue surprises of +20.00% and +2.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Here's What Investors Must Know Ahead of Weyerhaeuser's Q2 Earnings

WY's Q2 earnings are likely to dip 43% as Wood Products faces headwinds, but real estate gains could soften the blow.

Analysts Estimate Potlatch (PCH) to Report a Decline in Earnings: What to Look Out for

Potlatch (PCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wall Street's Insights Into Key Metrics Ahead of Weyerhaeuser (WY) Q2 Earnings

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Weyerhaeuser (WY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Weyerhaeuser Co. engages in the manufacture, distribution, and sale of forest products. It operates through the following segments: Timberlands, Real Estate, Energy, and Natural Resources (Real Estate and ENR), and Wood Products. The Timberlands segment manages private commercial forestland worldwide and engages in growing and harvesting trees for lumber, building, pulp, paper, and other wood products. The Real Estate and ENR segment delivers premiums to timber value by identifying and monetizing higher and better use lands and capturing the full value of surface and subsurface assets. The Wood Products segment delivers lumber, structural panels, engineered wood products and complementary building products for residential, multi-family, industrial, and light commercial applications. The company was founded by Frederick T. Weyerhaeuser on January 18, 1900 and is headquartered in Seattle, WA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.01	--	--	N/A
Q2 '25	$0.11	$0.12	12.83%	BEAT
Q1 '25	$0.10	$0.11	13.75%	BEAT
Q4 '24	$0.07	$0.11	58.59%	BEAT
Q3 '24	$0.00	$0.05	5370.46%	BEAT

WY
Weyerhaeuser Co.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest WY News

WY Weyerhaeuser Co.